Radient Technologies (Radient Technologies) ROCE % : 0.00% (As of Dec. 2022)

View and export this data going back to 2016. Start your Free Trial

What is Radient Technologies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Radient Technologies's annualized ROCE % for the quarter that ended in Dec. 2022 was 0.00%.

Radient Technologies ROCE % Historical Data

The historical data trend for Radient Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radient Technologies ROCE % Chart

Radient Technologies Annual Data

Trend

Dec13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

ROCE %

Get a 7-Day Free Trial

-71.74

-63.55

-81.38

-318.58

Radient Technologies Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
ROCE %	Get a 7-Day Free Trial															-	-	-	-	-

Radient Technologies ROCE % Calculation

Radient Technologies's annualized ROCE % for the fiscal year that ended in Mar. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2022 )		(A: Mar. 2021 )		(A: Mar. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2022 )		(A: Mar. 2021 )		(A: Mar. 2022 )
	=	-8.683	/	( ( (23.307 - 25.026)	+	(21.908 - 29.779) )	/ 2 )
	=	-8.683	/	( (-1.719	+	-7.871)	/ 2 )
	=	-8.683	/	-4.795
	=	181.08 %

Radient Technologies's ROCE % of for the quarter that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2022 )		(Q: Sep. 2022 )		(Q: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2022 )		(Q: Sep. 2022 )		(Q: Dec. 2022 )
	=	-2.256	/	( ( (21.062 - 30.79)	+	(20.607 - 31.154) )	/ 2 )
	=	-2.256	/	( ( -9.728	+	-10.547 )	/ 2 )
	=	-2.256	/	-10.1375
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2022) EBIT data.

Radient Technologies (OTCPK:RDDTF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Radient Technologies ROCE % Related Terms

Thank you for viewing the detailed overview of Radient Technologies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Radient Technologies (Radient Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Radient Technologies Inc (OTCPK:RDDTF) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

4035 101 St. NW, Edmonton, AB, CAN, T6E 0A4

Website

https://www.radientinc.com

Radient Technologies Inc is a Canadian company engaged in manufacturing cannabis derivatives, formulations, and products. It has developed its extraction process, Microwave Assisted Processing (MAP), which is used for producing a consistent product at industrial-scale quantities. It provides its customers and partners with white-label extracts, formulations, and finished products that contain a broad spectrum of cannabinoid and terpene profiles. While it operates in Canada and is building an additional facility in Germany. It operates in a single segment namely the production and sale of cannabis-related retail products.